| 1 | 1346242-81-6 | 厄达替尼 | ERDAFITINIB | C25H30N6O2
| 中间体 - 医药中间体 | |
| 2 | 115871-02-8 | L-Argininamide, L-phenylalanyl-N-2-naphthalenyl- | L-Argininamide, L-phenylalanyl-N-2-naphthalenyl- | C25H30N6O2
| | |
| 3 | | 2-Ethyl-N-[1-[2-methoxy-4-(1H-tetrazol-5-yl)benzyl]-1H-indol-6-yl]hexanamide | 2-Ethyl-N-[1-[2-methoxy-4-(1H-tetrazol-5-yl)benzyl]-1H-indol-6-yl]hexanamide | C25H30N6O2
| | |
| 4 | 810-16-2 | 4-[[(1,5-DIMETHYL-3-OXO-2-PHENYLPYRAZOL-4-YL)-METHYLAMINO]METHYL-METHYLAMINO]-1,5-DIMETHYL-2-PHENYLP | 4,4'-[methylenebis(methylimino)]bis[1,2-dihydro-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one] | C25H30N6O2
| 有机化工原料 | |
| 5 | 748812-53-5 | 依贝沙坦杂质A(EP) | 1-(Pentanoylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide | C25H30N6O2
| 对照品;医药中间体;杂质对照品;对照品-杂质对照品 | |
| 6 | | 1-Pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amide | 1-Pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amide | C25H30N6O2
| Irbesartan | |
| 7 | 850848-40-7 | 6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-(4-PIPERAZIN-1-YL-PHENYLAMINO)-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE | 6-Acetyl-8-cyclopentyl-5-methyl-2-(4-piperazin-1-yl-phenylamino)-8H-pyrido[2,3-d]pyrimidin-7-one | C25H30N6O2
| | |
| 8 | 1627826-19-0 | 化合物 CPL304110 | 1H-Benzimidazole, 2-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-6-(4-methyl-1-piperazinyl)- | C25H30N6O2
| | |
| 9 | 2230303-85-0 | 羟乙磺酸达尔西利杂质54 | 1,6-Naphthyridin-2(1H)-one, 3-acetyl-1-cyclopentyl-4-methyl-7-[[5-(4-piperidinyl)-2-pyrazinyl]amino]- | C25H30N6O2
| | |
| 10 | 1637781-04-4 | Dalpiciclib | 6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperidin-4-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one | C25H30N6O2
| | |
| 11 | 571189-84-9 | 羟乙磺酸达尔西利杂质12 | Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperidinyl)-2-pyridinyl]amino]- | C25H30N6O2
| | |